And Kwilasz et al. showed that TLR4 antagonists prevented the production of proinflammatory factors and motor dysfunction in the experimental autoimmune encephalomyelitis mouse model [38]. Here, TLR4 is linked to experimental autoimmune encephalomyelitis.